Drug ID | DDPD01150 |
|
Drug Name | Cefprozil | |
Molecular Weight | 389.426 | |
Molecular Formula | C18H19N3O5S | |
CAS Number | 92665-29-7 | |
SMILES | [H][C@]12SCC(C=CC)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O | |
External Links | ||
DRUGBANK | DB01150 | |
PubChem Compound | 5281006 | |
PDR | 1196 | |
Drugs.com | Drugs.com Drug Page |
Property Name | Property Value | Unit | Raw Value | Raw Unit | Reference |
---|---|---|---|---|---|
Log P | 0.6 | - | 0.6 | - | DRUGBANK |
Melting Point | 221.5 | ℃ | 218-225 | ℃ | DRUGBANK |
Water Solubility | 55.0 | mg/L | 55 | mg/L | DRUGBANK |
Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Reference |
---|---|---|---|---|---|---|
Bioavailability | 95.0 | % | 95 | % | DRUGBANK | |
Clearance | 0.18 | L/h/kg | 3.0 | ml/min/kg | fasting; | DRUGBANK | Clearance | 0.17 | L/h/kg | 2.9 | ml/min/kg | intravenous injection, IV; human, homo sapiens; | Human Intravenous Pharmacokinetic Dataset |
Volume of Distribution | 0.23 | L/kg | 0.23 | L/kg | DRUGBANK | Volume of Distribution | 0.21 | L/kg | 0.21 | L/kg | intravenous injection, IV; human, homo sapiens; | Human Intravenous Pharmacokinetic Dataset |
Half-life | 1.3 | h | 1.3 | h | DRUGBANK | Half-life | 1.2 | h | 1.2 | h | intravenous injection, IV; human, homo sapiens; | Human Intravenous Pharmacokinetic Dataset |
Protein Binding | 36.0 | % | 36 | % | DRUGBANK |
Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Brand Name | Component | Reference |
---|---|---|---|---|---|---|---|---|
Max dose for infants | 30.0 | mg/kg/day | 30 | mg/kg/day | PO, oral | Cefprozil | cefprozil | PDR |
Max dose for children | 30.0 | mg/kg/day | 30 | mg/kg/day | PO, oral | Cefprozil | cefprozil | PDR |
Max dose for adolescents | 1000.0 | mg/day | 1000 | mg/day | PO, oral | Cefprozil | cefprozil | PDR |
Max dose for adults | 1000.0 | mg/day | 1000 | mg/day | PO, oral | Cefprozil | cefprozil | PDR |
Max dose for geriatric | 1000.0 | mg/day | 1000 | mg/day | PO, oral | Cefprozil | cefprozil | PDR |